Going from concept to producing over a million clinically validated, FDA-compliant swabs in just a few weeks involved an enormous amount of collaboration and parallel development from domain experts. Hear from Origin CEO, Chris Prucha and Henkel’s 3D Printing Head of Innovation, Ken Kisner on how we worked together along with others to leverage each other’s strengths and get a validated 3D printed medical device to market in record time.
3D Printing Leadership Forum: Advances and Breakthroughs in 3D Printed Medical Equipment and Device Materials 3D printing has introduced all kinds... read more
Digital Light Processing (DLP) is an area-wide vat polymerization 3D printing process that uses an industrial-grade projector to cure multiple... read more
Our ecosystem partners, Nexa3D have been working closely with food & beverage giant Pepsi Co to change the way packaging... read more
Origin, manufacturer of stereolithography (SLA) 3D printers was one of the founding members of the consortium. It began working with... read more
We are very proud to announce the iMakr has officially joined forces with Henkel as a Tier 1 channel partner,... read more
As technology within the 3D printing industry continues to expand, there is a growing demand for strong and functional materials... read more
Henkel and Stratasys have teamed up with slicelab to put Dura56 to the test on the Bull Rider kick scooter.... read more
Our OEM partner, Origin, recently competed in the U.S Air Force Additive Manufacturing Olympics, in collaboration with Stress Engineering Services,... read more
Through recent partnership with Henkel, Nexa3D has now joined Henkel’s open platform of substance associates. As a result, the companies are... read more
A new collaboration between incubator businesses within Henkel’s Adhesives Technologies is bringing new industrial solutions to market. Together, Sonderhoff and... read more
Leave a Reply